Connect with us

Health

Report, Health News, ET HealthWorld

Published

on

COVID-19 found in raccoon dogs in China, strengthens natural origin theory: Report

New York: A new analysis of genetic samples collected from a seafood market in central China’s Wuhan city shows the presence of the SARS-CoV-2 virus in raccoon dogs sold at the venue, strengthening the case for the natural origin of the COVID-19 pandemic, according to a team of international experts.

The New York Times said in a report on Thursday that genetic data was drawn from swabs taken from in and around the Huanan Seafood Wholesale Market starting in January 2020, “shortly after the Chinese authorities had shut down the market because of suspicions that it was linked to the outbreak of a new virus.”

The new evidence comes weeks after an intelligence assessment from the US Department of Energy pointed out that an “accidental laboratory leak” from a virology laboratory in Wuhan was most likely the cause of the pandemic.

While the animals had been cleared out from the market, researchers took swabs from the walls, floors, metal cages and carts used for transporting animal cages, the report said.

“In samples that came back positive for the coronavirus, the international research team found genetic material belonging to animals, including large amounts that were a match for the raccoon dog,” it said, quoting three scientists involved in the analysis.

Advertisement

The report noted that after the international team came across the new data, it reached out to Chinese researchers who had uploaded the files with an offer to collaborate. However, after that, the sequences disappeared from GISAID (Global Initiative on Sharing Avian Influenza Data), it said.

The report said that the “jumbling together” of genetic material from the virus and the animal does not prove that a raccoon dog itself was infected. “And even if a raccoon dog had been infected, it would not be clear that the animal had spread the virus to people. Another animal could have passed the virus to people, or someone infected with the virus could have spread the virus to a raccoon dog,” the report said.

“But the analysis did establish that raccoon dogs — fluffy animals that are related to foxes and are known to be able to transmit the coronavirus — deposited genetic signatures in the same place where genetic material from the virus was left,” according to the scientists.

They noted that the evidence was “consistent” with a scenario in which the virus had spilled into humans from a wild animal. “But the genetic data from the market offers some of the most tangible evidence yet of how the virus could have spilled into people from wild animals outside a lab. It also suggests that Chinese scientists have given an incomplete account of evidence that could fill in details about how the virus was spreading at the Huanan market,” the report said.

The international team included an evolutionary biologist at the University of Arizona Michael Worobey; a virologist at the Scripps Research Institute in California Kristian Andersen and a biologist at the University of Sydney Dr Edward Holmes. They started mining the new genetic data last week.

Advertisement

“One sample, in particular, caught their attention. It had been taken from a cart linked to a specific stall at the Huanan market that Holmes had visited in 2014,” the report said. That stall contained “caged raccoon dogs” on top of a separate cage holding birds, “exactly the sort of environment conducive to the transmission of new viruses.”

“We were able to figure out relatively quickly that at least in one of these samples, there was a lot of raccoon dog nucleic acid, along with virus nucleic acid,” said Stephen Goldstein, a virologist at the University of Utah who worked on the new analysis.

Goldstein cautioned that “we don’t have an infected animal, and we can’t prove definitively there was an infected animal at that stall.” “But given that the animals that were present in the market were not sampled at the time, this is as good as we can hope to get,” the virologist said.

The first coronavirus case was reported in China’s Wuhan Province in December 2019. Globally, there have been 760,360,956 confirmed cases of COVID-19, including 6,873,477 deaths, according to the World Health Organisation.

Advertisement

Health

Adenoiditis: Causes, who is at risk, signs and symptoms, diagnosis, treatment | Health

Published

on

By

Adenoiditis is a type of health condition wherein the adenoids (tissue behind the nose and above the throat) gets inflamed and it is common among children and leads to problems like snoring, mouth breathing, recurrent ear infections, decreased hearing, difficulty in breathing, cracked lips, runny nose and bad breath. Adenoiditis occurs when there is inflammation of the adenoid tissue resulting from infection, allergies or irritation from stomach acid as a component of laryngopharyngeal reflux (LPR).

Adenoiditis: Causes, who is at risk, signs and symptoms, diagnosis, side effects, treatment (Photo by Twitter/DrMary_Alphonse)
Adenoiditis: Causes, who is at risk, signs and symptoms, diagnosis, side effects, treatment (Photo by Twitter/DrMary_Alphonse)

In an interview with HT Lifestyle, Dr Nitty Mathew, Senior Specialist – ENT at Aster CMI Hospital, revealed, “Adenoiditis is usually caused by an infection of adenoids. Adenoids become apparent by 2 years of age and regress in size after 8 years. If these remain swollen for a prolonged time, then they can become problematic.”

Highlighting who is at risk of developing adenoiditis, she shared that since adenoids usually shrink by adulthood, children are most susceptible to its infection. They can be more prone to developing adenoiditis if the child is

● Bottle fed

● Breast fed in lying down position

Advertisement

● Have an infection near the nose or throat

● Suffering from an allergy

According to her, the symptoms of adenoiditis include:

● Stuffy and blocked nose

● Snoring

Advertisement

● Sleep apnea

● Cracked lips, dry mouth

● Glue ear

● Ear pain and infections

● Swollen neck glands

Advertisement

She said, “To diagnose adenoiditis, your doctor will conduct a check-up of your child’s nose, ears, mouth and throat. In case the symptoms are worse, your doctor may also suggest he/she undergo an X-ray to see degree of enlargement of adenoids and obstruction of nasal airway.”

Talking about the side effects of adenoiditis, Dr Nitty Mathew pointed out that the complications of untreated adenoiditis include –

● Runny nose

● Recurrent ear infections, decreased hearing

● Dry mouth, Dental caries

Advertisement

● Speaking with a nasal tone

● Adenoid facies

The health expert added, “Adenoid facies is defined as the open -mouthed appearance in children, associated with a narrow nose, shortened upper lip, narrow palate, high palatal vault and dental crowding.” She concluded, “Usually by 8years of age adenoids regress, but keeping good hygiene can prevent repeated infections. Mild symptoms warrants only supportive treatment, but if your doctor suspects any bacterial infection then the child will have to be treated with antibiotics and then kept on nasal sprays to decrease the size of adenoids. In case the medications are not bringing intended relief of symptoms, then a surgery called adenoidectomy to remove the enlarged adenoids will have to be done.”

Advertisement
Continue Reading

Health

Researchers explain: What causes long Covid breathing problems

Published

on

By

Researchers at Stanford University have found that people are experiencing breathing problems post Covid-19 due to a condition known as lung fibrosis in which the damaged lungs form scar tissue, that makes it difficult for the lungs to expand and contract.

The research showed that overactivity of genes that regulate inflammation and immune responses leads to lung fibrosis.

Long Covid cases can be severely debilitating and resistant to treatment, said Gerlinde Wernig, Assistant Professor of pathology, at Stanford University.

What`s worse, lung function can continue to decline, even without a new Covid-19 infection, Wernig said.

Advertisement

The finding published in the Proceedings of the National Academy of Sciences offers hope that, one day, targeted drugs could intervene to quell the genes behind the damage.

In the study, the team started by looking at lung tissue samples from five Covid-19 patients who had symptoms of the disease — such as shortness of breath — for one or more months. The lungs of people who had symptoms after infection with SARS-CoV-2 looked like the lungs of people with end-stage pulmonary fibrosis.

By analysing single cells from the patients` tissue samples, the scientists also saw similarities in the pattern of RNA production — which can hint a cell`s overall function — between samples of tissue from long Covid patients and samples from patients with pulmonary fibrosis.

“We saw this same pattern across all human Covid lung samples,” Wernig said.

As with other lung infections, the initial Covid-19 infection in the lungs kicked off an inflammatory process. In the case of long-Covid patients, however, the immune dysfunction keeps going long after the virus is gone — similar to what happens in chronic pulmonary fibrosis.

Advertisement

To test whether lung fibrosis could be firmly connected to Covid infections, they looked at lung fibrosis in mice infected with a SARS-CoV-2-like virus and found significant increases in fibrosis and immune dysfunction.

“Innate immune cells go crazy after that infection,” Wernig said, referring to the part of the immune system that forms the first line of defence against pathogens.

In a mouse model engineered to more closely represent human biology, researchers showed that, when the mice contracted SARS-CoV-2, scarring in the lung tissues shot up, as did levels of immune cells interleukin-6, CD47 and pJUN. There was also a bright side to these experiments.

“When we did the same experiments but blocked CD47 and Il-6, we saw very little fibrosis,” Wernig said. “This hints at possible treatments for long Covid involving drugs that carry out targeted immune blockades.”

Also Read: Mumbai: All wards have Covid-19 cases; only one critical

Advertisement

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Continue Reading

Health

89Bio’s NASH drug meets main goals of mid-stage study, Health News, ET HealthWorld

Published

on

By

89Bio's NASH drug meets main goals of mid-stage study

New Delhi: Drug developer 89Bio Inc said on Wednesday its treatment for a liver disease called non-alcoholic steatohepatitis met the main goals of a mid-stage trial, sending its shares up 50 per cent in premarket trading.

The company’s experimental drug, Pegozafermin, demonstrated at least one-stage fibrosis improvement without worsening of NASH and NASH resolution without worsening of fibrosis in both trial doses.

89Bio said the data supports advancement to late-stage development.

Follow and connect with us on , Facebook, Linkedin, Youtube

Advertisement

Continue Reading

Trending